Identification of the needs of individuals affected by COVID-19.
Journal
Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676
Informations de publication
Date de publication:
09 May 2024
09 May 2024
Historique:
received:
30
05
2023
accepted:
25
04
2024
medline:
10
5
2024
pubmed:
10
5
2024
entrez:
9
5
2024
Statut:
epublish
Résumé
The optimal management of COVID-19 symptoms and their sequelae remains an important area of clinical research. Policy makers have little scientific data regarding the effects on the daily life of affected individuals and the identification of their needs. Such data are needed to inform effective care policy. We studied 639 people with COVID-19 resident in France via an online questionnaire. They reported their symptoms, effects on daily life, and resulting needs, with particular focus on olfaction. The results indicate that a majority of participants viewed their symptoms as disabling, with symptoms affecting their physical and mental health, social and professional lives. 60% of the individuals reported having unmet medical, psychological and socio-professional support needs. Finally, affected individuals were concerned about the risk and invasiveness of possible treatments as shown by a preference for non-invasive intervention over surgery to cure anosmia. It is important that policy makers take these needs into consideration in order to assist affected individuals to regain a normal quality of life. The impact of COVID-19 has been substantial, both on individuals’ health and on society. Information is needed to understand the biological mechanisms underlying the illness and to provide appropriate support for people affected. This study uses data from an online questionnaire of adults diagnosed with COVID-19 to characterize symptoms, understand their impact on peoples’ everyday lives, and determine the support that people need. Our over-arching analysis of symptoms experienced reveals that heart- and skin-related symptoms are linked to chronic illness, and symptoms related to the sense of smell may have a different underlying disease mechanism. Most respondents had a mild initial illness, but their symptoms were long-lasting and had a severe impact. Our findings show that sufferers need different kinds of support in order to regain a normal quality of life.
Sections du résumé
BACKGROUND
BACKGROUND
The optimal management of COVID-19 symptoms and their sequelae remains an important area of clinical research. Policy makers have little scientific data regarding the effects on the daily life of affected individuals and the identification of their needs. Such data are needed to inform effective care policy.
METHODS
METHODS
We studied 639 people with COVID-19 resident in France via an online questionnaire. They reported their symptoms, effects on daily life, and resulting needs, with particular focus on olfaction.
RESULTS
RESULTS
The results indicate that a majority of participants viewed their symptoms as disabling, with symptoms affecting their physical and mental health, social and professional lives. 60% of the individuals reported having unmet medical, psychological and socio-professional support needs. Finally, affected individuals were concerned about the risk and invasiveness of possible treatments as shown by a preference for non-invasive intervention over surgery to cure anosmia.
CONCLUSIONS
CONCLUSIONS
It is important that policy makers take these needs into consideration in order to assist affected individuals to regain a normal quality of life.
The impact of COVID-19 has been substantial, both on individuals’ health and on society. Information is needed to understand the biological mechanisms underlying the illness and to provide appropriate support for people affected. This study uses data from an online questionnaire of adults diagnosed with COVID-19 to characterize symptoms, understand their impact on peoples’ everyday lives, and determine the support that people need. Our over-arching analysis of symptoms experienced reveals that heart- and skin-related symptoms are linked to chronic illness, and symptoms related to the sense of smell may have a different underlying disease mechanism. Most respondents had a mild initial illness, but their symptoms were long-lasting and had a severe impact. Our findings show that sufferers need different kinds of support in order to regain a normal quality of life.
Autres résumés
Type: plain-language-summary
(eng)
The impact of COVID-19 has been substantial, both on individuals’ health and on society. Information is needed to understand the biological mechanisms underlying the illness and to provide appropriate support for people affected. This study uses data from an online questionnaire of adults diagnosed with COVID-19 to characterize symptoms, understand their impact on peoples’ everyday lives, and determine the support that people need. Our over-arching analysis of symptoms experienced reveals that heart- and skin-related symptoms are linked to chronic illness, and symptoms related to the sense of smell may have a different underlying disease mechanism. Most respondents had a mild initial illness, but their symptoms were long-lasting and had a severe impact. Our findings show that sufferers need different kinds of support in order to regain a normal quality of life.
Identifiants
pubmed: 38724573
doi: 10.1038/s43856-024-00510-1
pii: 10.1038/s43856-024-00510-1
doi:
Types de publication
Journal Article
Langues
eng
Pagination
83Informations de copyright
© 2024. The Author(s).
Références
WHO COVID-19 Dashboard. World Health Organisation https://covid19.who.int/info (2020).
Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259–264 (2021).
pubmed: 33887749
doi: 10.1038/s41586-021-03553-9
Perlis, R. H. et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw. Open 5, e2238804 (2022).
pubmed: 36301542
pmcid: 9614581
doi: 10.1001/jamanetworkopen.2022.38804
Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med. 27, 626–631 (2021).
pubmed: 33692530
pmcid: 7611399
doi: 10.1038/s41591-021-01292-y
Landry, M. et al. Postacute Sequelae of SARS-CoV-2 in University Setting. Emerg Infect. Dis. 29, 519–527 (2023).
pubmed: 36703253
pmcid: 9973677
doi: 10.3201/eid2903.221522
Tan, B. K. J. et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ https://doi.org/10.1136/bmj-2021-069503 (2022).
Pavli, A., Theodoridou, M. & Maltezou, H. C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 52, 575–581 (2021).
pubmed: 33962805
pmcid: 8093949
doi: 10.1016/j.arcmed.2021.03.010
Sugiyama, A. et al. Long COVID occurrence in COVID-19 survivors. Sci. Rep. 12, 6039 (2022).
pubmed: 35411017
pmcid: 8996498
doi: 10.1038/s41598-022-10051-z
Nasserie, T., Hittle, M. & Goodman, S. N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw. Open 4, e2111417 (2021).
pubmed: 34037731
pmcid: 8155823
doi: 10.1001/jamanetworkopen.2021.11417
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583–590 (2022).
pubmed: 35132265
pmcid: 8938267
doi: 10.1038/s41591-022-01689-3
Grant, M. C. et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 15, e0234765 (2020).
pubmed: 32574165
pmcid: 7310678
doi: 10.1371/journal.pone.0234765
Buckley, B. J. R. et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 51, e13679 (2021).
pubmed: 34516657
pmcid: 8646627
doi: 10.1111/eci.13679
Xie, Y., Xu, E. & Al-Aly, Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ 376, e068993 (2022).
pubmed: 35172971
doi: 10.1136/bmj-2021-068993
Boscolo-Rizzo, P. et al. Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up. Int. Forum Allergy Rhinol. 13, 1864–1875 (2023).
pubmed: 36852674
doi: 10.1002/alr.23148
Xu, E., Xie, Y. & Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406–2415 (2022).
pubmed: 36138154
pmcid: 9671811
doi: 10.1038/s41591-022-02001-z
Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114–119 (2021).
pubmed: 33915568
pmcid: 8814825
doi: 10.1038/s41586-021-03569-1
Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107–113 (2021).
pubmed: 33915569
pmcid: 8919505
doi: 10.1038/s41586-021-03570-8
Eberhardt, N. et al. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat. Cardiovasc. Res. 2, 899–916 (2023).
pubmed: 38076343
pmcid: 10702930
doi: 10.1038/s44161-023-00336-5
Frere, J. J. et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl Med. 14, eabq3059 (2023).
doi: 10.1126/scitranslmed.abq3059
Faghy, M. A. et al. COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life. Expert Rev. Respir. Med. 16, 595–600 (2022).
pubmed: 35385677
doi: 10.1080/17476348.2022.2063843
Briggs, A. & Vassall, A. Count the cost of disability caused by COVID-19. Nature 593, 502–505 (2021).
pubmed: 34040204
doi: 10.1038/d41586-021-01392-2
Kay, L. M. COVID-19 and olfactory dysfunction: a looming wave of dementia? J. Neurophysiol. 128, 436–444 (2022).
pubmed: 35894511
pmcid: 9377782
doi: 10.1152/jn.00255.2022
Steinmetz, A. et al. The Greifswald Post COVID Rehabilitation Study and Research (PoCoRe)–Study Design, Characteristics and Evaluation Tools. J. Clin. Med. 12, 624 (2023).
pubmed: 36675551
pmcid: 9861069
doi: 10.3390/jcm12020624
OECD. Investing in health systems to protect society and boost the economy: Priority investments and order-of-magnitude cost estimates (abridged version). OECD Policy Responses to Coronavirus (COVID-19) https://www.oecd.org/coronavirus/policy-responses/investing-in-health-systems-to-protect-society-and-boost-the-economy-priority-investments-and-order-of-magnitude-cost-estimates-abridged-version-94ba313a/ (2022).
Stanley, H. B. & Bensafi, M. A data set of symptoms and needs of individuals affected by COVID-19. Nat. Sci. Data 11, 122 (2024).
Bussiere, N. et al. Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up. Chem. Senses 47, bjac010 (2022).
pubmed: 35522081
doi: 10.1093/chemse/bjac010
Doty, R. L. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health. Trends Mol. Med. 28, 781–794 (2022).
pubmed: 35810128
pmcid: 9212891
doi: 10.1016/j.molmed.2022.06.005
Boscolo-Rizzo, P. et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology 59, 517–527 (2021).
pubmed: 34553706
Watson, D. L. B. et al. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19. PLoS One 16, e0256998 (2021).
doi: 10.1371/journal.pone.0256998
Connelly, D. ‘My whole world changed’: The repulsive smells that linger for months post COVID. Pharmaceutical J. 308, No. 7960 (2022)
Tan, N. K. W. et al. The burden of prolonged smell and taste loss in covid-19. BMJ 378, o1895 (2022).
pubmed: 35896196
doi: 10.1136/bmj.o1895
Barrea, L. et al. Dietary Recommendations for Post-COVID-19 Syndrome. Nutrients 14, https://doi.org/10.3390/nu14061305 (2022).
Ferrulli, A., Senesi, P., Terruzzi, I. & Luzi, L. Eating Habits and Body Weight Changes Induced by Variation in Smell and Taste in Patients with Previous SARS-CoV-2 Infection. Nutrients 14, 5068 (2022).
pubmed: 36501098
pmcid: 9738767
doi: 10.3390/nu14235068
Bernard Stoecklin, S. et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro. Surveill. 25, 2000094 (2020).
pubmed: 32070465
pmcid: 7029452
doi: 10.2807/1560-7917.ES.2020.25.6.2000094
Eurostat. Daily smokers of cigarettes by sex, age and educational attainment level. https://ec.europa.eu/eurostat/databrowser/view/HLTH_EHIS_SK3E__custom_6000386/default/table?lang=en&page=time:2019 (2019).
Fox, J. & Weisberg, S. Companion to Applied Regression 3rd edn (Sage, 2020).
The_jamovi_project. jamovi version 2.2.5 [computer software]. https://www.jamovi.org (2021).
Newcombe, R. & Altman, D. in Statistics with Confidence Ch. 6 (BMJ Books, 2017).
Lin, L. et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69, 997–1001 (2020).
pubmed: 32241899
doi: 10.1136/gutjnl-2020-321013
Cagnazzo, F. et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J. Neurol. 268, 2656–2665 (2021).
pubmed: 33125542
doi: 10.1007/s00415-020-10285-9
Caruso, D. et al. Post-acute sequelae of COVID-19 pneumonia: Six-month chest CT follow-up. Radiology 301, E36–E405 (2021).
doi: 10.1148/radiol.2021210834
Struyf, T. et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst. Rev. 2022, CD013665 (2022).
Vaira, L. A. et al. COVID-19 related persistent olfactory disorders represent an unprecedented challenge. Am. J. Otolaryngol. 44, 103667 (2023).
pubmed: 36270236
doi: 10.1016/j.amjoto.2022.103667
Cooper, K. W. et al. COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. Neuron 107, 219–233 (2020).
pubmed: 32640192
pmcid: 7328585
doi: 10.1016/j.neuron.2020.06.032
Zhao, Y.-H., Zhao, L., Yang, X.-C. & Wang, P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis. Rev. Cardiovasc. Med. 22, 159–165 (2021).
pubmed: 33792257
doi: 10.31083/j.rcm.2021.01.238
Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet 399, 1618–1624 (2022).
pubmed: 35397851
pmcid: 8989396
doi: 10.1016/S0140-6736(22)00327-0
Kalish, H. et al. Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci. Transl. Med. 13, eabh3826 (2021).
pubmed: 34158410
pmcid: 8432952
doi: 10.1126/scitranslmed.abh3826
Vihta, K. D. et al. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciac613 (2022).
Byambasuren, O. et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. J. Assoc. Med. Microbiol. Infectious Dis. Can. 5, 223–234 (2020).
Tande, A. J. et al. Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening. Clin. Infect. Dis. 74, 59–65 (2022).
pubmed: 33704435
doi: 10.1093/cid/ciab229
Stankevice, D., Fjaeldstad, A. W., Agergaard, J. & Ovesen, T. Long-Term COVID-19 Smell and Taste Disorders Differ Significantly from Other Post-Infectious Cases. Laryngoscope 133, 169–174 (2023).
pubmed: 36305529
doi: 10.1002/lary.30453
Makaronidis, J. et al. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in peopl. BMC Infect. Dis. 21, 221 (2021).
pubmed: 33632171
pmcid: 7905973
doi: 10.1186/s12879-021-05927-w
Kaye, R., Chang, C. W. D., Kazahaya, K., Brereton, J. & Denneny, J. C. COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol. Head Neck Surg. 163, 132–134 (2020).
pubmed: 32340555
doi: 10.1177/0194599820922992
Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Oto Rhino Laryngol. 277, 2251–2261 (2020).
doi: 10.1007/s00405-020-05965-1
Groff, A. et al. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner. J. 21, 177–180 (2021).
pubmed: 34239378
pmcid: 8238098
doi: 10.31486/toj.20.0086
Jason, L. A. et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue 9, 59–68 (2021).
pubmed: 34484973
pmcid: 8411893
Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-022-00846-2 (2023)
Polly, S. & Fernandez, A. P. Common skin signs of COVID-19 in adults: An update. Cleve Clin. J. Med. 89, 161–167 (2022).
pubmed: 35232829
doi: 10.3949/ccjm.89a.21126
Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).
pubmed: 34308300
pmcid: 8280690
doi: 10.1016/j.eclinm.2021.101019
Apple, A. C. et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann. Clin. Transl. Neurol. 9, 221–226 (2022).
pubmed: 35043593
pmcid: 8862406
doi: 10.1002/acn3.51498
Croy, I., Nordin, S. & Hummel, T. Olfactory Disorders and Quality of Life—An Updated Review. Chem. Senses 39, 185–194 (2014).
pubmed: 24429163
doi: 10.1093/chemse/bjt072
Keller, A. & Malaspina, D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear. Nose Throat Disord. 13, 8 (2013).
pubmed: 23875929
pmcid: 3733708
doi: 10.1186/1472-6815-13-8
Manesse, C. et al. Dysosmia-Associated Changes in Eating Behavior. Chemosens. Percept. 10, 104–113 (2017).
doi: 10.1007/s12078-017-9237-3
Manesse, C. et al. The prevalence of olfactory deficits and their effects on eating behavior from childhood to old age: A large-scale study in the French population. Food Qual. Prefer. 93, 104273 (2021).
Ferdenzi, C. et al. Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study. Chem. Senses 46, bjab028 (2021).
pubmed: 34097726
doi: 10.1093/chemse/bjab028
Bousquet, C., Bouchoucha, K., Bensafi, M. & Ferdenzi, C. Phantom smells: a prevalent COVID-19 symptom that progressively sets in. Eur. Arch. Otorhinolaryngol 280, 1219–1229 (2023).
pubmed: 36173444
doi: 10.1007/s00405-022-07649-4
Lassale, C. et al. Healthy dietary indices and risk of depressive outcomes: asystematic review and meta-analysis of observational studies. Mol. Psychiatry 24, 965–986 (2019).
pubmed: 30254236
doi: 10.1038/s41380-018-0237-8
Salari-Moghaddam, A., Saneei, P., Larijani, B. & Esmaillzadeh, A. Glycemic index, glycemic load, and depression: a systematic review and meta-analysis. Eur. J. Clin. Nutr. 73, 356–365 (2019).
pubmed: 30054563
doi: 10.1038/s41430-018-0258-z
Kaiser, A., Schaefer, S. M., Behrendt, I., Eichner, G. & Fasshauer, M. Association of sugar intake from different sources with incident depression in the prospective cohort of UK Biobank participants. Eur. J. Nutr. https://doi.org/10.1007/s00394-022-03022-7 (2022).
Yom-Tov, E., Lekkas, D. & Jacobson, N. C. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J. Affect. Disord. Rep. 5, 100156 (2021).
pubmed: 34075369
pmcid: 8154197
doi: 10.1016/j.jadr.2021.100156
Croy, I. & Hummel, T. Olfaction as a marker for depression. J. Neurol. 264, 631–638 (2017).
pubmed: 27393116
doi: 10.1007/s00415-016-8227-8
Mahmut, M. K. & Croy, I. The role of body odors and olfactory ability in the initiation, maintenance and breakdown of romantic relationships—A review. Physiol. Behav. 207, 179–184 (2019).
pubmed: 31077678
doi: 10.1016/j.physbeh.2019.05.003
Lübke, K. T. & Pause, B. M. Always follow your nose: The functional significance of social chemosignals in human reproduction and survival. Horm. Behav. 68, 134–144 (2015).
pubmed: 25637403
doi: 10.1016/j.yhbeh.2014.10.001
Otte, M. S. et al. Impact of COVID-19-Mediated Olfactory Loss on Quality of Life. ORL J. Otorhinolaryngol. Relat. Spec. 85, 1–6 (2023).
pubmed: 35413715
doi: 10.1159/000523893
OECD. State of Health in the EU: Country Health Profiles France: Country Health Profile 2021. https://read.oecd-ilibrary.org/social-issues-migration-health/france-country-health-profile-2021_7d668926-en#page1 (2021).
Besser, G., Liu, D. T., Renner, B., Hummel, T. & Mueller, C. A. Olfactory implant: Demand for a future treatment option in patients with olfactory dysfunction. Laryngoscope 129, 312–316 (2019).
pubmed: 30145818
doi: 10.1002/lary.27476
Pinger, M. et al. Perceived utility of electronic noses in patients with loss of smell. Eur. Arch. Oto Rhino Laryngol. 278, 2155–2156 (2021).
doi: 10.1007/s00405-021-06708-6
Sheeran, P., Webb, T. L. & Gollwitzer, P. M. The Interplay Between Goal Intentions and Implementation Intentions. Pers. Soc. Psychol. Bull. 31, 87–98 (2005).
pubmed: 15574664
doi: 10.1177/0146167204271308
Bohns, V. K. & Flynn, F. J. “Why didn’t you just ask?” Underestimating the discomfort of help-seeking. J Exp. Soc. Psychol. 46, 402–409 (2010).
doi: 10.1016/j.jesp.2009.12.015
Schnell, R., Noack, M. & Torregroza, S. Differences in general health of internet users and non-users and implications for the use of web surveys. Surv. Res. Methods 11, 105–123 (2017).
Deems, D. A. et al. Smell and Taste Disorders, A Study of 750 Patients From the University of Pennsylvania Smell and Taste Center. Arch. Otolaryngol. Head Neck Surg. 117, 519–528 (1991).
pubmed: 2021470
doi: 10.1001/archotol.1991.01870170065015
Doty, R. L. Measurement of chemosensory function. World J. Otorhinolaryngol. Head Neck. Surg. 4, 11–28 (2018).
pubmed: 30035257
pmcid: 6051764
doi: 10.1016/j.wjorl.2018.03.001
Ohla, K. et al. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinol. J. 60, 207–217 (2022).
Fernández-de-las-Peñas, C. et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 11, https://doi.org/10.3390/jcm11020413 (2022).
Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020).
pubmed: 32087114
pmcid: 7159018
doi: 10.1016/S1473-3099(20)30120-1
de Bellefon, M.-P. (PSAR A. territoriale-I., Eusebio, P. ((PSAR A. territoriale-I., Forest, J. ((PSAR A. territoriale-I. & Warnod, R. ((PSAR A. territoriale-I. 38% de la population française vit dans une commune densément peuplée. Statistiques et études https://www.insee.fr/fr/statistiques/4252859 (2019).
INSEE. Population statistics of France. https://www.insee.fr/fr/statistiques/1893198 (2022).
Bensafi, M. & Stanley, H. B. COVID-19—Symptoms—Impact on quality of life and needs of affected people. Zenodo https://doi.org/10.5281/zenodo.7920303 (2023).
Stanley, H. B. & Bensafi, M. A data set of symptoms and needs of individuals affected by COVID-19. Sci Data 11, 122 (2024).
pubmed: 38267450
pmcid: 10808179
doi: 10.1038/s41597-024-02961-6